R&D 4 years on: Remembering the COVID-19 pandemic This year, Monday 11th March marked four years since the World Health Organization (WHO) declared COVID-19 a global pandemic.
R&D Disease X is coming. Are we ready? Every great disaster movie begins with a scientist being ignored.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.